The development of Lapdap, an affordable new treatment for malaria

This publication has 19 references indexed in Scilit:

• Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial
  The Lancet, 2002
• Drug development for neglected diseases: a deficient market and a public-health policy failure
  The Lancet, 2002
• Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania
  The Lancet, 2001
• Molecular Evidence of Greater Selective Pressure for Drug Resistance Exerted by the Long‐Acting Antifolate Pyrimethamine/Sulfadoxine Compared with the Shorter‐Acting Chlorproguanil/Dapsone on KenyanPlasmodium falciparum
  The Journal of Infectious Diseases, 2000
• Efficacy of sulphadoxine‐pyrimethamine for acute uncomplicated malaria due to Plasmodium falciparum in Malawian children under five years old
  Tropical Medicine & International Health, 2000
• Chemotherapy for Falciparum Malaria: The Armoury, the Problems and the Prospects
  Parasitology Today, 2000
• The Global Drug Gap
  Science, 2000
• The efficacy of pyrimethamine-sulfadoxine (Fansidar®) in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 2000
• Resistance to pyrimethamine/sulfadoxine in Plasmodium falciparum in 12 villages in north east Tanzania and a test of chlorproguanil/dapsone
  Acta Tropica, 1997
• A preliminary pharmacokinetic study of the antimalarial drugs, proguanil and chlorproguanil
  Journal of Pharmacy and Pharmacology, 1987